CardiAQ Valve Technologies closes $6.5M Series A
Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming...
Search for Articles
Jan 12, 2010
Jun 9, 2009
miRagen Therapeutics, Inc. extends Series A to $12M
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA...
May 13, 2009
CardiAQ Valve Technologies receives seed funding from Broadview Ventures
CardiAQ Valve Technologies (CVT) received $750,000 in seed or ‘translational’ funding from Broadview Ventures Inc.—a...